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INTRODUCTION 
Schwann cells (SCs), the glial cells of the peripheral nervous 
system, are highly plastic and are thought to be the key players 
in successful regeneration following nerve injury. Recently, 
the use of Schwann cell therapy, including therapies using SCs 
derived from skin (SKPSCs), has shown much potential for 
improving clinical outcomes after nerve injury. One of the 
primary mechanisms by which SKPSCs appear to enhance 
recovery is via the regulation of cellular responses responsible 
for the clearance of debris [1]. Indeed, strong evidence shows 
factors (ie. cytokines) released by SCs post-injury play vital 
roles in recruiting and regulating macrophages, the chief 
phagocytic cells responsible for clearing debris. In particular, 
interkeukin-6 (IL6), a pleiotropic cytokine upregulated after 
nerve injury, is thought to play an important role in 
macrophage recruitment and phenotype regulation, important 
for successful regeneration [2,3]. Even with this thought-to-be 
beneficial role that IL6 appears to play, others have 
demonstrated that IL6 can play deleterious roles in the nerve 
as well, for example causing extensive demyelination 
following its administration in uninjured nerves [4]. The 
dichotomous nature of IL6 in the nerve is context specific, 
highly complex and yet to be fully understood. Because we 
have recently identified IL6 as being expressed by SKPSCs at 
levels 20x higher than most other cytokines, and this cytokine 
is notorious for being a potent regulator of the immune 
system, we set out to determine the complex role of IL6 
following SKPSC transplant in the injured nerve. 
METHODS 
We used an antibody against IL6, either in the presence or 
absence of SKPSC transplants to assess whether IL6 
neutralization resulted in altered functional and histological 
outcomes. We performed crush injury in the sciatic nerves of 
adult Lewis rats and immediately treated each nerve with 
either: media+IgG, media+α-IL6, SKPSCs+IgG or 
SKPSCs+α-IL6, followed by IgG or α-IL6 injections at day 1, 
3 & 6 post-injury (n=6-8 per group). SKPSCs, previously 
derived and characterized from adult Lewis rats, were 
administered at 500,000 per nerve with both antibodies 
administered at 0.08μg/nerve (sourced from R&D). We used 
compound muscle action potential (CMAP) analysis and 
muscle weight assessments to determine gastrocnemius 
muscle reinnervation and immunohistochemistry to assess 
cellular responses within treated injured sciatic nerves.  
RESULTS 
Peak CMAP amplitudes were highest with SKPSC+α-IL6 
treatment (9.01mV max), compared to SKPSCs+IgG (2.93mV 
max), media+α-IL6 (6.28mV max) and media+IgG (4.46mV 
max) treatment controls at 4 weeks post injury (Fig 1A-D). 
Muscle weights were 10-20% higher in the SKPSCs+α-IL6 
treated group compared to controls. We demonstrated that 
SKPSC transplant enhanced macrophage densities compared 
to media controls at 1 week post-injury, although there was no 
observable difference between SKPSCs+α-IL6 & 
SKPSCs+IgG treated groups (Fig1 A’-D’). 
  
 
 
Figure 1. A-E) CMAP readings of the gastrocnemius muscle at 4 weeks post 
nerve injury. Representative CMAP traces from uninjured nerves (A) or 
injured nerves treated with media+IgG (B), media+α-IL6 (C), SKPSCs+IgG 
(D) or SKPSCs+α-IL6 (E) demonstrates an increase in peak CMAP 
amplitudes (P) following SKPSCs+α-IL6 treatment compared to injured 
controls. A’-E’) Representative immunohistochemical images demonstrating 
the presence of Iba1+ macrophages (red) in the proximal stump of an injured 
nerve (A’) or the distal stump of injured nerves at 1 week post-crush injury, 
treated with or without GFP+ SKPSCs (green) and antibody. Note the increase 
in the density of Iba1+ cells in SKPSCs+IgG (D’) and SKPSCs+α-IL6 (E’) 
treated groups compared to media+IgG (B’) and media+α-IL6 (C’) groups 
assessed at 3mm distal to the crush site. Scale bar = 250 µm. 
DISCUSSION AND CONCLUSIONS 
IL6 neutralization+SKPSCs had no effect on macrophage 
densities compared to controls suggesting that the observed 
functional benefits of SKPSCs+α-IL6 treatment is not due to 
early effects on macrophages densities post-injury. Future 
experiments will interrogate the long-term and complex role of 
IL6 and SKPSCs on the injured nerve.  
 
REFERENCES 
1.  Khoung H, et al. Exp Neuro. 254: 168-179, 2014 2.  Tofaris GK, et al. J 
Neurosci. 22(15): 6696-6703, 2002 3.  Zhong et al. J Neurosci. 19(11): 4305-
4313, 1999 4. Deretzi et al. Immunology 97(4): 582-587, 1999 
